SHSSX Holdings Information

SHSSX is a mutual fund with a total of 163 individual holdings. The top holdings are Eli Lilly and Company stock at 12.29%, Johnson & Johnson at 7.96%, UnitedHealth Group at 6.10%, Merck & Co. at 4.94%, and Gilead Sciences at 4.19%.

Total Holdings

163

Top 10 Percentage

51.15%

Asset Class

Equity

Fund Category

Health

Assets

5.91B

Forward PE Ratio

18.94

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.29%	656,650
2	JNJ	Johnson & Johnson	7.96%	2,085,034
3	UNH	UnitedHealth Group Incorporated	6.10%	947,412
4	MRK	Merck & Co., Inc.	4.94%	2,456,466
5	GILD	Gilead Sciences, Inc.	4.19%	1,841,333
6	ABBV	AbbVie Inc.	3.94%	1,068,019
7	AMGN	Amgen Inc.	3.37%	590,203
8	TMO	Thermo Fisher Scientific Inc.	3.02%	362,337
9	VRTX	Vertex Pharmaceuticals Incorporated	2.74%	361,907
10	PFE	Pfizer Inc.	2.61%	5,899,018
11	EW	Edwards Lifesciences Corporation	2.51%	1,710,975
12	ELV	Elevance Health, Inc.	2.01%	302,439
13	DHR	Danaher Corporation	2.00%	645,138
14	ABT	Abbott Laboratories	1.97%	1,361,894
15	ISRG	Intuitive Surgical, Inc.	1.95%	271,432
16	TEVA	Teva Pharmaceutical Industries Limited	1.87%	3,121,339
17	BSX	Boston Scientific Corporation	1.59%	1,945,032
18	ARGX	argenx SE	1.26%	88,995
19	LON: AZN	AstraZeneca PLC	1.21%	384,355
20	BIIB	Biogen Inc.	1.21%	364,188
21	SYK	Stryker Corporation	1.15%	221,948
22	RVMD	Revolution Medicines, Inc.	0.96%	361,340
23	HUM	Humana Inc.	0.92%	178,205
24	REGN	Regeneron Pharmaceuticals, Inc.	0.91%	87,659
25	BMY	Bristol-Myers Squibb Company	0.89%	917,026

Showing 25 of 163 holdings

Subscribe to see the full list

Activate Now

As of May 31, 2026